| 今开：1.44 | 昨收：1.44 |
| 最高：1.46 | 最低：1.39 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.91007E7 |
Marinus(MRNS)02-07 01:05
$Marinus制药(MRNS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000038777-24-000017 Act: 34 Size: 188 KB 网页链接查看全文
Marinus(MRNS)02-07 20:35
$Marinus制药(MRNS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001150 Act: 34 Size: 96 KB 网页链接查看全文
Marinus(MRNS)02-14 23:15
$Marinus制药(MRNS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001635 Act: 34 Size: 71 KB 网页链接查看全文
Marinus(MRNS)03-28 00:05
$Marinus制药(MRNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009175 Size: 7 KB 网页链接查看全文
chuminhua04-16 14:17
4/15，Marinus Pharmaceuticals$Marinus(MRNS)$ 披露，其癫痫药物，GABA 受体调节剂加奈索酮（ganaxolone）的中期分析未能满足提前停止标准，该公司股价周一暴跌 80% 以上。
元羿生物通过一项超2.6亿美元的合作获得了其在大中华区开发和商业化的独家权利。去年已在国内提交上市申请。
III ...查看全文
Marinus(MRNS)04-19 18:15
$Marinus(MRNS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-007131 Act: 34 Size: 85 KB 网页链接查看全文
Marinus(MRNS)02-23 05:15
$Marinus制药(MRNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004781 Size: 5 KB 网页链接查看全文
Marinus(MRNS)02-22 05:15
$Marinus制药(MRNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004576 Size: 5 KB 网页链接查看全文
Marinus(MRNS)02-15 01:25
$Marinus制药(MRNS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001580642-24-000985 Act: 34 Size: 54 KB 网页链接查看全文
Marinus(MRNS)02-15 04:15
$Marinus制药(MRNS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000651 Act: 34 Size: 87 KB 网页链接查看全文
2024年3月27日， Marinus制药（MRNS）披露1笔公司内部人交易情况。董事Braunstein Scott于2024年3月27日买入5.00万股。 【近期内部交易】 披露日期职位姓名交易日期买/卖数量每股成交价/美元总金额/美元2024年3月27日董事Braunstein... 网页链接
格隆汇3月21日丨Marinus制药(MRNS.US)跌11.85%，报8.815美元。该公司今日发布财报，截至12月31日的季度营收为150万美元，而去年同期为150万美元，远低于市场预期的350万美元；第四季度每股亏损0.77美元，而一年前同期亏损0.55美元，高于市... 网页链接
$Marinus(MRNS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-007131 Act: 34 Size: 85 KB 网页链接
$Marinus(MRNS)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001104659-24-046976 Act: 34 Size: 237 KB 网页链接
$Marinus(MRNS)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-004691 Act: 34 Size: 2 MB 网页链接
$Marinus(MRNS)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-004693 Act: 34 Size: 428 KB 网页链接
$Marinus制药(MRNS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-039703 Act: 34 Size: 226 KB 网页链接
$Marinus制药(MRNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009175 Size: 7 KB 网页链接
$Marinus制药(MRNS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002479 Act: 34 Size: 10 MB 网页链接
$Marinus制药(MRNS)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-002473 Act: 34 Size: 12 MB 网页链接
$Marinus制药(MRNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004781 Size: 5 KB 网页链接
$Marinus制药(MRNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004782 Size: 5 KB 网页链接